AatmaNirbhar Bharat: Mankind Pharma All Set to Rollout Cheapest Covid Drug Molnupiravir
Tuesday, February 7, 2023
  • Circulation
  • Advertise
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
SUBSCRIBE
No Result
View All Result
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • G20
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • My States
  • Vocal4Local
  • Subscribe
Home Bharat

AatmaNirbhar Bharat: Mankind Pharma All Set to Rollout Cheapest Covid Drug Molnupiravir

WEB DESK by WEB DESK
Jan 4, 2022, 03:30 pm IST
in Bharat, Delhi
The recommended dose of Molnupiravir is 1600 mg per day for five days (Photo Credit: Times of India)

The recommended dose of Molnupiravir is 1600 mg per day for five days (Photo Credit: Times of India)

Share on FacebookShare on TwitterTelegramEmail

Mankind Pharma will sell it with a brand name Molulife, and the full course will cost Rs 1399.

 

The Indian pharma major, Mankind Pharma is all set to roll out the Covid-19 drug Molnupiravir at the cost of Rs 1399 for the full course.

Molnupiravir, developed by US-based MSD has been approved by the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) and the US regulator Food and Drug Administration (FDA) for the treatment of mild-to-moderate Covid-19 patients who are at high risk of developing severe disease.

Many Indian pharma companies, including Cipla, Sun Pharma, Dr Reddy's, Mankind Pharma, Torrent Pharma, have entered a 'non-exclusive voluntary licencing agreement' with MSD to manufacture and supply Molnupiravir in India and over 100 other low and middle-income countries (LMICs).

The recommended dose of Molnupiravir is 1600 mg per day for five days.

In a press statement on December 23, MSD said, "Molnupiravir has not been approved, but has been authorized for emergency use by the FDA under an EUA to treat mild to moderate coronavirus disease 2019 (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate."

It added, "Molnupiravir is not authorized for patients who are less than 18 years of age, for initiation of treatment in patients hospitalized due to COVID-19, for use for longer than five consecutive days, or pre-exposure or post-exposure prophylaxis for prevention of COVID-19."

India's Covid-19 vaccination drive has been commenced for adolescents of 15-18 age bracket from Monday (January 3), and more than 40 lakh adolescents got vaccinated on the first day. While Bharat Biotech's Covaxin is currently being administered for adolescents between 15-18, Serum Institute's Covishield and Bharat Biotech's Covaxin are administered for adults above 18.

The Central Drugs Standard Control Organisation (CDSCO) approved the Serum Institute of India's Covid-19 vaccine Covovax and Biological E's vaccine Corbevax in the last week of December. The country has administered more than 145 crore Covid-19 vaccine doses so far.

 

ShareTweetSendShareSend
Previous News

PM Modi’s development push in Manipur; We bring the central government to the doorstep of the people of Manipur and North East

Next News

Indian Army unfurls national flag in Galwan valley on New Year

Related News

Grammy Awards 2023: Proud moment for India, Music composer Ricky Kej wins 3rd Grammy

Grammy Awards 2023: Proud moment for India, Music composer Ricky Kej wins 3rd Grammy

Hindenburg Controversy: A Malafide intent to halt India’s economic growth

Hindenburg Controversy: A Malafide intent to halt India’s economic growth

“No CPM, No Sports” under communist-ruled Kerala; IOA President P T Usha alleges security threat to her sports academy

“No CPM, No Sports” under communist-ruled Kerala; IOA President P T Usha alleges security threat to her sports academy

Bharat Jodo Yatra: Kashmir just a photo Op?

Bharat Jodo Yatra: Kashmir just a photo Op?

Remembering Lata Mangeshkar on her death anniversary; tracing her journey in Film industry

Remembering Lata Mangeshkar on her death anniversary; tracing her journey in Film industry

Bangladesh at risk of Islamists returning to power

Bangladesh at risk of Islamists returning to power

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Grammy Awards 2023: Proud moment for India, Music composer Ricky Kej wins 3rd Grammy

Grammy Awards 2023: Proud moment for India, Music composer Ricky Kej wins 3rd Grammy

Hindenburg Controversy: A Malafide intent to halt India’s economic growth

Hindenburg Controversy: A Malafide intent to halt India’s economic growth

“No CPM, No Sports” under communist-ruled Kerala; IOA President P T Usha alleges security threat to her sports academy

“No CPM, No Sports” under communist-ruled Kerala; IOA President P T Usha alleges security threat to her sports academy

Bharat Jodo Yatra: Kashmir just a photo Op?

Bharat Jodo Yatra: Kashmir just a photo Op?

Remembering Lata Mangeshkar on her death anniversary; tracing her journey in Film industry

Remembering Lata Mangeshkar on her death anniversary; tracing her journey in Film industry

Bangladesh at risk of Islamists returning to power

Bangladesh at risk of Islamists returning to power

Assam: 14-year-old Hindu girl abducted and gangraped by Bhaijan Ali and Safar Ali in Dibrugarh

Assam: 14-year-old Hindu girl abducted and gangraped by Bhaijan Ali and Safar Ali in Dibrugarh

IRCTC’s new service: Indian Railways launches WhatsApp food delivery facility for passengers

IRCTC’s new service: Indian Railways launches WhatsApp food delivery facility for passengers

India Energy Week 2023: “India continues to be global bright spot in a world stricken with Covid & war,” says PM Modi

India Energy Week 2023: “India continues to be global bright spot in a world stricken with Covid & war,” says PM Modi

Can’t accept demand of separate Tipraland; will open a pandora’s box in the region: NEDA convenor Himanta Biswa Sarma

Can’t accept demand of separate Tipraland; will open a pandora’s box in the region: NEDA convenor Himanta Biswa Sarma

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • My States
  • Vocal4Local
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Subscribe
  • Advertise
  • Circulation
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Refund and Cancellation

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies